Live from the NIH registry
Studies recruiting near Lake Charles right now
Top 25 of 27 recruiting studies, sorted by proximity — each links to its official registry page
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
Lupus Erythematosus, Systemic
Phase 3
Interventional 600 participants sought
Accurate Clinical Research, Inc. — Lake Charles, Louisiana (0.9 mi)
· Sponsor: Janssen Research & Development, LLC
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
Phase 3
Interventional 762 participants sought
89bio Clinical Study Site — Lake Charles, Louisiana (0.9 mi)
· Sponsor: 89bio, Inc.
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
Pulmonary Disease, Chronic Obstructive
Phase 3
Interventional 1,196 participants sought
GSK Investigational Site — Lake Charles, Louisiana (0.9 mi)
· Sponsor: GlaxoSmithKline
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
Systemic Lupus Erythematosus
Phase 3
Interventional 550 participants sought
Accurate Clinical Research — Lake Charles, Louisiana (0.9 mi)
· Sponsor: Novartis Pharmaceuticals
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response
Arthritis, Psoriatic
Phase 3
Interventional 600 participants sought
Clinical Site — Lake Charles, Louisiana (0.9 mi)
· Sponsor: MoonLake Immunotherapeutics AG
A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition (START SYNERGY)
Active Rheumatoid Arthritis
Phase 2
Interventional 180 participants sought
Accurate Clinical Research Inc (SMO/ Network) — Lake Charles, Louisiana (0.9 mi)
· Sponsor: Elevara Medicines Limited
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Phase 3
Interventional 1,350 participants sought
89bio Clinical Study Site — Lake Charles, Louisiana (0.9 mi)
· Sponsor: 89bio, Inc.
An Extension Study to Assess Long-Term Safety and Efficacy of Afimkibart in Participants With Rheumatoid Arthritis
Rheumatoid Arthritis
Phase 2
Interventional 120 participants sought
Accurate Clinical Research Inc. — Lake Charles, Louisiana (0.9 mi)
· Sponsor: Hoffmann-La Roche
A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis
Rheumatoid Arthritis
Phase 2
Interventional 320 participants sought
Research Site — Lake Charles, Louisiana (0.9 mi)
· Sponsor: AstraZeneca
Study of GS-0151 in Participants With Rheumatoid Arthritis
Rheumatoid Arthritis
Phase 1
Interventional 75 participants sought
Accurate Clinical Research, Inc — Lake Charles, Louisiana (0.9 mi)
· Sponsor: Gilead Sciences
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University Telemedicine — Lake Charles, Louisiana (0.9 mi)
· Sponsor: Sameek Roychowdhury
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
Obesity, Overweight
Phase 3
Interventional 1,980 participants sought
Care Access - Lake Charles (Bayou Pines) — Lake Charles, Louisiana (0.9 mi)
· Sponsor: Eli Lilly and Company
A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-1)
Pulmonary Disease, Chronic Obstructive
Phase 3
Interventional 624 participants sought
GSK Investigational Site — Lake Charles, Louisiana (0.9 mi)
· Sponsor: GlaxoSmithKline
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
Psoriatic Arthritis
Phase 3
Interventional 1,088 participants sought
Accurate Clinical Research, Inc. | Lake Charles — Lake Charles, Louisiana (0.9 mi)
· Sponsor: Takeda
Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain
Chemotherapy Induced Neuropathic Pain, Chemotherapy Induced Pain Neuropathy
Phase 2
Interventional 240 participants sought
Central Recruiting Site — Lake Charles, Louisiana (0.9 mi)
· Sponsor: Dogwood Therapeutics Inc.
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Lumbar Spinal Stenosis
N/A
Observational 8,000 participants sought
Lake Charles Memorial Hospital — Lake Charles, Louisiana (0.9 mi)
· Sponsor: Stryker Instruments
A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)
Psoriatic Arthritis, Overweight or Obesity
Phase 4
Interventional 200 participants sought
Accurate Clinical Research, Inc — Lake Charles, Louisiana (0.9 mi)
· Sponsor: Eli Lilly and Company
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
Cardiovascular Disease
Phase 3
Interventional 15,100 participants sought
Research Site — Lake Charles, Louisiana (0.9 mi)
· Sponsor: AstraZeneca
A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight and Chronic Low Back Pain
Obesity, Overweight
Phase 3
Interventional 586 participants sought
Care Access - Lake Charles (Bayou Pines) — Lake Charles, Louisiana (0.9 mi)
· Sponsor: Eli Lilly and Company
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Plaque Psoriasis
Phase 3
Interventional 3,040 participants sought
Shondra L. Smith, MD - Dermatology and Advanced Aesthetics — Lake Charles, Louisiana (0.9 mi)
· Sponsor: Bristol-Myers Squibb
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
Primary Sjogren's Disease
Phase 3
Interventional 250 participants sought
Accurate Clinical Research, Inc. — Lake Charles, Louisiana (0.9 mi)
· Sponsor: Vor Biopharma
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)
Systematic Lupus Erythematosus, Cutaneous Lupus Erythematosus
Phase 3
Interventional 202 participants sought
Accurate Clinical Research Inc. - Lake Charles — Lake Charles, Louisiana (0.9 mi)
· Sponsor: EMD Serono Research & Development Institute, Inc.
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
Phase 3
Interventional 450 participants sought
Sl0044 50285 — Lake Charles, Louisiana (0.9 mi)
· Sponsor: UCB Biopharma SRL
Efficacy and Safety of IMVT-1402 in Adult Participants With Primary Sjogren's Disease With Moderate to Severe Systemic Disease Activity
Primary Sjögren's Syndrome
Phase 2
Interventional 180 participants sought
Site Number - 1030 — Lake Charles, Louisiana (0.9 mi)
· Sponsor: Immunovant Sciences GmbH
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
Alzheimer Disease, Dementia
Phase 3
Interventional 550 participants sought
Care Access - Lake Charles (Bayou Pines) — Lake Charles, Louisiana (0.9 mi)
· Sponsor: Eli Lilly and Company